AAAAAA

   
Results: 1-16 |
Results: 16
APOLIPOPROTEIN-E AND APOLIPOPROTEIN-B IN VLDL ARE FACTOR-XIII, SUBSTRATES - A ROLE FOR TRANSGLUTAMINASE-INDUCED CROSS-LINKING IN ATHEROGENESIS
Authors: SOBEL JH POKROVSKY SN CANFIELD RE JONES J BERGLUND L
Citation: Jh. Sobel et al., APOLIPOPROTEIN-E AND APOLIPOPROTEIN-B IN VLDL ARE FACTOR-XIII, SUBSTRATES - A ROLE FOR TRANSGLUTAMINASE-INDUCED CROSS-LINKING IN ATHEROGENESIS, Circulation, 98(17), 1998, pp. 2022-2022
LIPOPROTEIN(A) IS A BIOCHEMICAL MARKER OF CORONARY ATHEROSCLEROSIS
Authors: EZHOV MV AFANASYEVA OI BENEVOLENSKAYA GF SAVCHENKO AP LYAKISHEV AA POKROVSKY SN
Citation: Mv. Ezhov et al., LIPOPROTEIN(A) IS A BIOCHEMICAL MARKER OF CORONARY ATHEROSCLEROSIS, Terapevticeskij arhiv, 69(9), 1997, pp. 31-34
RELATIONSHIP BETWEEN HIGH LIPOPROTEIN (A) LEVEL AND SEVERE CORONARY ATHEROSCLEROSIS IN PATIENTS WITH ISCHEMIC-HEART-DISEASE WITH NORMAL PLASMA-CONCENTRATION OF CHOLESTEROL AND TRIGLYCERIDES
Authors: EZHOV MV LYAKISHEV AA MATCHIN YG POKROVSKY SN
Citation: Mv. Ezhov et al., RELATIONSHIP BETWEEN HIGH LIPOPROTEIN (A) LEVEL AND SEVERE CORONARY ATHEROSCLEROSIS IN PATIENTS WITH ISCHEMIC-HEART-DISEASE WITH NORMAL PLASMA-CONCENTRATION OF CHOLESTEROL AND TRIGLYCERIDES, Kardiologia, 37(11), 1997, pp. 18-22
RELATION OF LIPOPROTEIN LP(A) CONCENTRATION AND APOLIPOPROTEIN APO(A)PHENOTYPES TO THE PRESENCE AND SEVERITY OF CAROTID ATHEROSCLEROSIS
Authors: AFANASIEVA OI EZHOV MV BENEVOLENSKAYA GF BALAKHONOVA TV LYAKISHEV AA POKROVSKY SN
Citation: Oi. Afanasieva et al., RELATION OF LIPOPROTEIN LP(A) CONCENTRATION AND APOLIPOPROTEIN APO(A)PHENOTYPES TO THE PRESENCE AND SEVERITY OF CAROTID ATHEROSCLEROSIS, Atherosclerosis, 134(1-2), 1997, pp. 136-136
APOLIPOPROTEIN(A) PHENOTYPES AS A PREDICTOR OF OCCLUSIONS IN CORONARY-ARTERIES
Authors: EZHOV MV AFANASIEVA OI BENEVOLENSKAYA GF SAVCHENKO AP LYAKISHEV AA POKROVSKY SN
Citation: Mv. Ezhov et al., APOLIPOPROTEIN(A) PHENOTYPES AS A PREDICTOR OF OCCLUSIONS IN CORONARY-ARTERIES, Atherosclerosis, 134(1-2), 1997, pp. 140-140
LP(A) APHERESIS NEW APPROACH FOR SPECIFIC LP(A) LOWERING
Authors: POKROVSKY SN SUSSEKOV AV AFANASIEVA OI ADAMOVA IY KUKHARCHUK VV
Citation: Sn. Pokrovsky et al., LP(A) APHERESIS NEW APPROACH FOR SPECIFIC LP(A) LOWERING, Atherosclerosis, 134(1-2), 1997, pp. 147-147
EFFECT OF REPEATED LP(A) APHERESIS ON METABOLIC PARAMETERS OF LIPOPROTEIN(A)
Authors: YAROVAYA YB SUSSEKOV AV AFANASIEVA OI POKROVSKY SN KUKHARCHUK VV
Citation: Yb. Yarovaya et al., EFFECT OF REPEATED LP(A) APHERESIS ON METABOLIC PARAMETERS OF LIPOPROTEIN(A), Atherosclerosis, 134(1-2), 1997, pp. 152-152
LP(A) AS A POSSIBLE BIOCHEMICAL MARKER FOR VEIN GRAFT STENOSIS AFTER CORONARY-ARTERY BYPASS-SURGERY
Authors: POKROVSKY SN VLASOVA EY ILINA LN AFANASIEVA OI SHIRYAEV AA AGAPOV AA AKCHURIN RS
Citation: Sn. Pokrovsky et al., LP(A) AS A POSSIBLE BIOCHEMICAL MARKER FOR VEIN GRAFT STENOSIS AFTER CORONARY-ARTERY BYPASS-SURGERY, Atherosclerosis, 134(1-2), 1997, pp. 166-166
IMMUNOSORBENT FOR IGG APHERESIS - AN IN-VITRO STUDY
Authors: KISELEVA EA AFANASIEVA OI KOSHELEVA NA POKROVSKY SN
Citation: Ea. Kiseleva et al., IMMUNOSORBENT FOR IGG APHERESIS - AN IN-VITRO STUDY, Transfusion science, 17(4), 1996, pp. 519-525
DO ASCORBIC-ACID, LYSINE AND THEIR COMBIN ATION AFFECT LIPOPROTEIN(A)LEVEL IN PATIENTS WITH ISCHEMIC-HEART-DISEASE
Authors: EZHOV MV AFANASYEVA OI KONONOVA OI MIRONOVA IY LYAKISHEV AA POKROVSKY SN
Citation: Mv. Ezhov et al., DO ASCORBIC-ACID, LYSINE AND THEIR COMBIN ATION AFFECT LIPOPROTEIN(A)LEVEL IN PATIENTS WITH ISCHEMIC-HEART-DISEASE, Kardiologia, 36(9), 1996, pp. 31-33
IMMEDIATE AND ONE-YEAR RESULTS OF CORONAR Y-BYPASS SURGERY - RELATIONTO HYPERLIPIDEMIA
Authors: AGAPOV AA VLASOVA EE AKCHURIN RS TITOV VN SAVCHENKO AP SOBOLEV AV POKROVSKY SN
Citation: Aa. Agapov et al., IMMEDIATE AND ONE-YEAR RESULTS OF CORONAR Y-BYPASS SURGERY - RELATIONTO HYPERLIPIDEMIA, Kardiologia, 36(12), 1996, pp. 13-17
DEVELOPMENT OF IMMUNOSORBENTS FOR APO-B-CONTAINING LIPOPROTEINS APHERESIS
Authors: POKROVSKY SN SUSSEKOV AV ADAMOVA IY AFANASIEVA OI BENEVOLENSKAYA GF KONOVALOV GA KUKHARCHUK VV
Citation: Sn. Pokrovsky et al., DEVELOPMENT OF IMMUNOSORBENTS FOR APO-B-CONTAINING LIPOPROTEINS APHERESIS, Artificial organs, 19(6), 1995, pp. 500-505
FIBRINOLYSIS AND LIPID-TRANSPORT SYSTEM I N PATIENTS WITH DIFFERENT EXTENT OF ATHEROSCLEROSIS
Authors: PANCHENKO EP DOBROVOLSKY AB PEROVA NV POKROVSKY SN KISLYAKOVA EA DAVLETOV KK KARPOV YA
Citation: Ep. Panchenko et al., FIBRINOLYSIS AND LIPID-TRANSPORT SYSTEM I N PATIENTS WITH DIFFERENT EXTENT OF ATHEROSCLEROSIS, Kardiologia, 35(12), 1995, pp. 72-77
EXTRACORPOREAL IMMUNOADSORPTION FOR THE SPECIFIC REMOVAL OF LIPOPROTEIN (A) (LP(A) APHERESIS) - PRELIMINARY CLINICAL-DATA
Authors: POKROVSKY SN SUSSEKOV AV AFANASIEVA OI ADAMOVA IY LYAKISHEV AA KUKHARCHUK VV
Citation: Sn. Pokrovsky et al., EXTRACORPOREAL IMMUNOADSORPTION FOR THE SPECIFIC REMOVAL OF LIPOPROTEIN (A) (LP(A) APHERESIS) - PRELIMINARY CLINICAL-DATA, Chemistry and physics of lipids, 67-8, 1994, pp. 323-330
ATHEROSCLEROSIS OF MAJOR HEAD ARTERIES AN D LEVELS OF PLASMA LIPOPROTEIN-(A)
Authors: VARAKIN YY OSCHEPKOVA YV SKVORTSOV AV ADAMOVA IY DZHIBLADZE DN ARABIDZE GG POKROVSKY SN
Citation: Yy. Varakin et al., ATHEROSCLEROSIS OF MAJOR HEAD ARTERIES AN D LEVELS OF PLASMA LIPOPROTEIN-(A), Terapevticeskij arhiv, 65(3), 1993, pp. 54-56
USE OF IMMUNOSORPTION FOR SELECTIVE DECRE ASE IN LIPOPROTEIN(A) LEVELS IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
Authors: SUSEKOV AV AFANASYEVA OI ADAMOVA IY LYAKISHEV AA KUKHARCHUK VV POKROVSKY SN
Citation: Av. Susekov et al., USE OF IMMUNOSORPTION FOR SELECTIVE DECRE ASE IN LIPOPROTEIN(A) LEVELS IN PATIENTS WITH CORONARY ATHEROSCLEROSIS, Kardiologia, 32(11-12), 1992, pp. 52-56
Risultati: 1-16 |